Physician profile
Charles H Smith
NPI 1053383950
$754.90
in general payments reported to CMS, 2019-2025
16 companies · $599 in 2025
The $599 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.75 · 2023: $66.08 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $158.80 | 2025 | Airsupra, Farxiga |
| Inari Medical, INC. | $89.75 | 2021 | |
| Amgen INC. | $80.97 | 2023-2025 | Repatha, Evenity, Prolia |
| Astellas Pharma US INC | $73.53 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $55.74 | 2025 | Vaxneuvance, Rotateq, Capvaxive |
| Pfizer INC. | $52.94 | 2025 | |
| Abbvie INC. | $37.02 | 2025 | |
| Dexcom, INC. | $32.02 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $30.10 | 2025 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $26.78 | 2025 | Nimbl, Flexitouch Plus |
| Glaxosmithkline, LLC. | $25.80 | 2025 | Trelegy Ellipta |
| Lilly USA, LLC | $23.06 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $20.67 | 2025 | Nexplanon |
| Novo Nordisk INC | $18.61 | 2025 | Wegovy |
| Kowa Pharmaceuticals America, INC. | $15.09 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $14.02 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.